Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:21 pm Sale | 2023-12-31 | 13G | VERSARTIS INC ARAV | Baker Bros. Advisors LP | 3,863,568 4.990% | -722,836 (-15.76%) | Filing History |
| 2024-02-14 10:24 am Purchase | 2023-12-31 | 13G | VERSARTIS INC ARAV | BIOTECHNOLOGY VALUE FUND L P | 8,164,510 9.990% | 2,055,452 (+33.65%) | Filing History |
| 2024-02-09 5:14 pm Sale | 2023-12-31 | 13G | VERSARTIS INC ARAV | Artal International S.C.A. | 7,609,522 9.400% | -4,572,515 (-37.53%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | VERSARTIS INC ARAV | Baker Bros. Advisors LP | 4,586,404 7.500% | 3,160,094 (+221.56%) | Filing History |
| 2023-02-10 7:28 pm Purchase | 2022-12-31 | 13G | VERSARTIS INC ARAV | Artal International S.C.A. | 12,182,037 9.900% | 10,870,746 (+829.01%) | Filing History |
| 2022-12-28 4:00 pm Purchase | 2022-10-27 | 13D | VERSARTIS INC ARAV | Zhang Eric | 2,029,634 3.400% | 1,169,868 (+136.07%) | Filing History |
| 2022-12-27 4:05 pm Purchase | 2022-10-27 | 13D | VERSARTIS INC ARAV | Giaccia Amato | 1,725,244 2.900% | 546,932 (+46.42%) | Filing History |
| 2022-11-07 4:50 pm Purchase | 2022-10-27 | 13G | VERSARTIS INC ARAV | BIOTECHNOLOGY VALUE FUND L P | 6,109,058 9.990% | 6,109,058 (New Position) | Filing History |
| 2022-11-03 4:45 pm Purchase | 2022-10-24 | 13D | VERSARTIS INC ARAV | Eshelman Ventures LLC | 26,451,103 43.600% | 26,451,103 (New Position) | Filing History |
| 2022-04-05 4:15 pm Purchase | 2022-03-29 | 13D | VERSARTIS INC ARAV | ESHELMAN FREDRIC N | 10,111,882 34.000% | 5,806,201 (+134.85%) | Filing History |
| 2022-02-11 4:48 pm Unchanged | 2021-12-31 | 13G | VERSARTIS INC ARAV | New Leaf Biopharma Opportunities II L.P. | 946,423 4.500% | 0 (Unchanged) | Filing History |
| 2022-01-05 6:32 pm Purchase | 2022-01-03 | 13D | VERSARTIS INC ARAV | ESHELMAN FREDRIC N | 4,305,681 19.990% | 472,828 (+12.34%) | Filing History |